Mohammed Ali Balghith1. 1. King Abdulaziz Cardiac Center, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Abstract
BACKGROUND: The reperfusion therapy using primary percutaneous coronary intervention (PPCI) in ST-segment elevation myocardial infarction (STEMI) is known to give a better result than fibrinolytic therapy. The fast access to PPCI will improve hospital outcome. We believe that patient access to PPCI facility would have improved due to enhanced public awareness and expanding evidenced-based health provision. METHODS: This is a single-center retrospective study to analyze and compare data for STEMI patients. Patients were transferred to our hospital during the year 2010. Group l comprised 223 patients. Group 2 comprised 288 patients. Group 2 patients were those treated between August 2014 and August 2015. We compared their demographic and baseline characteristics, patients' access to the hospital, reasons for no access, and hospital mortality for the two groups. RESULTS: Among the 288 patients in Group 2, 247 patients (85%) were males with an average age of 57 years, 49% were diabetics, 48% were hypertensive, 48% were smokers, and 27% were obese. These were not different in Group 1. In Group 2, 164 patients (57%) only had access to PPCI compared to 56% in Group 1 (P = 0.536-NS). In G2, the main reasons for no PPCI were late presentation in 47% versus 53% in Group 1; P = 0.34 NS. In Group 2, 27% were due to thrombolysis versus 17% in Group 1 (P = 0.11 NS). Hospital mortality in Group 2 was 4% in those treated with PPCI compared to 2.3% in Group 1 (P = 0.522-NS). Mortality in patients who did not receive PPCI in Group 2 was 8% compared to 11.3% in Group 1 (P = 0.49-NS). Females in Group 2 have about 3 times higher mortality. Patients treated for STEMI in the last 12 months at King Abdulaziz Cardiac Center still have relatively low access to PPCI due mainly to persistent pattern of late presentation and prior thrombolysis, which reflect apparent lack of direct access to hospitals with PPCI facilities. CONCLUSION: Comparing the two periods, there was no change in cardiology practice. The low access to PPCI was mainly due to late presentation and prior thrombolysis. Hospital mortality rate for patients treated with PPCI remained low during the two era. This seemingly relates to both lack of public awareness and health provision factors in PPCI organizations. Copyright:
BACKGROUND: The reperfusion therapy using primary percutaneous coronary intervention (PPCI) in ST-segment elevation myocardial infarction (STEMI) is known to give a better result than fibrinolytic therapy. The fast access to PPCI will improve hospital outcome. We believe that patient access to PPCI facility would have improved due to enhanced public awareness and expanding evidenced-based health provision. METHODS: This is a single-center retrospective study to analyze and compare data for STEMI patients. Patients were transferred to our hospital during the year 2010. Group l comprised 223 patients. Group 2 comprised 288 patients. Group 2 patients were those treated between August 2014 and August 2015. We compared their demographic and baseline characteristics, patients' access to the hospital, reasons for no access, and hospital mortality for the two groups. RESULTS: Among the 288 patients in Group 2, 247 patients (85%) were males with an average age of 57 years, 49% were diabetics, 48% were hypertensive, 48% were smokers, and 27% were obese. These were not different in Group 1. In Group 2, 164 patients (57%) only had access to PPCI compared to 56% in Group 1 (P = 0.536-NS). In G2, the main reasons for no PPCI were late presentation in 47% versus 53% in Group 1; P = 0.34 NS. In Group 2, 27% were due to thrombolysis versus 17% in Group 1 (P = 0.11 NS). Hospital mortality in Group 2 was 4% in those treated with PPCI compared to 2.3% in Group 1 (P = 0.522-NS). Mortality in patients who did not receive PPCI in Group 2 was 8% compared to 11.3% in Group 1 (P = 0.49-NS). Females in Group 2 have about 3 times higher mortality. Patients treated for STEMI in the last 12 months at King Abdulaziz Cardiac Center still have relatively low access to PPCI due mainly to persistent pattern of late presentation and prior thrombolysis, which reflect apparent lack of direct access to hospitals with PPCI facilities. CONCLUSION: Comparing the two periods, there was no change in cardiology practice. The low access to PPCI was mainly due to late presentation and prior thrombolysis. Hospital mortality rate for patients treated with PPCI remained low during the two era. This seemingly relates to both lack of public awareness and health provision factors in PPCI organizations. Copyright:
The majority of patients with ST-segment elevation myocardial infarction (STEMI) diagnosis, who arrive in a facility with access to catheterization laboratory (Cath Lab), will achieve an excellent benefit from rapid reperfusion by the primary percutaneous coronary intervention (PPCI) than from fibrinolytic therapy.[1] At the same time, fibrinolysis is an equal alternative for patients with no access to a Cath Lab facility with percutaneous coronary intervention (PCI).[2] The American College of Cardiology/American Heart Association recommends a maximum delay of 90 min between first medical contact (FMC) and balloon inflation for PPCI.[3] The delays of fast coronary intervention were associated with re-hospitalization with heart failure and STEMI, and this may lead to more deaths.[45]A timely access to reperfusion therapy and Cath lab facility seems to be more beneficial and significant than other treatment strategy. The initiation and development of an integrated system of care will permit timely access to Cath lab facilities. This will allow patients to have appropriate care within the required time.During myocardial infarction, the timing of revascularization is very important. Delays do occur: (1) prehospital delay – the interval between FMC and arrival at a Cath Lab Facility and (2) door-to-balloon (D2B) interval.[67]The following variables have been demonstrated to reduce D2B delay with respect to prehospital intervals: improvement of prehospital care protocols, with prehospital diagnosis of STEMI by electrocardiogram (ECG) recording and interpretation during ambulance transport; prehospital activation of cardiac catheterization laboratory; direct referral to PCI center without interhospital transfers; and emergency department (ED) bypass at the PCI center.[8910]By reducing prehospital system delays, new and integrative approaches to STEMI patient care can improve access to PCI in rural populations that would not otherwise have timely access.The objective of our study is to evaluate whether or not any difference happened in the STEMI management between 2010 and 2015 regarding access to PPCI and awareness.[111213]
METHODS
Study population
This study was a retrospective, single-center, observational study conducted at King Abdulaziz Cardiac Center (KACC). All patients who were admitted between August 2014 and August 2015 with a diagnosis of STEMI were included and classified according to their access to PPCI, and we compared the outcome with the patients who had STEMI in 2010.
Definition
STEMI patient was defined as new onset of chest pain with ECG criteria of ST-segment elevation of at least >0.1 mV all leads, minimum of two consecutive leads, ≥0.2 mV for V1–V3, or new or presumably new left bundle branch block accompanying chest pain. Serum cardiac biomarkers used to assist in the diagnosis of myocardial injury were positive.
Statistical analysis
We used Student's t-test to compare continuous variables and Chi-square test to compare categorical variables to assess group differences. All tests were two-sided, with a 5% level of significance. Statistical analysis was done using IBM®SPSS® version 23.
RESULTS
A total number 288 patients (Group 2) were diagnosed with STEMI; 247 patients (85%) were males with average age of 57 years. Nearly 49% were diabetics, 48% hypertensive, 48% were smokers, and 27% were obese [Table 1].
Table 1
Baseline characteristics of both groups
Group 2
Group 1
Number
288
223
Age(mean)
57y
56y
Sex(M)
85%
83%
DM
49%
52%
HTN
48%
46%
Smoker
48%
45%
Obesity
27%
26%
Hyperlipidemia
52%
52%
Baseline characteristics of both groupsThese were not different in (Group 1) 223 patients. Of Group 2, 164 patients (57%) only had access to PPCI compared to 56% in Group 1 (P = 0.536-NS) [Figure 1].
Figure 1
The difference in both groups for primary percutaneous coronary intervention versus non.primary percutaneous coronary intervention
The difference in both groups for primary percutaneous coronary intervention versus non.primary percutaneous coronary interventionIn Group 2, the main reasons for no PPCI were late presentation in 47% versus 53% in Group 1; P = 0.34 NS and 27% due to thrombolysis versus 17% in Group 1 (P = 0.11 NS) [Figure 2].
Figure 2
The difference in both groups for late presentation versus thrombolysis
The difference in both groups for late presentation versus thrombolysisHospital mortality in Group 2 was 4% in those treated with PPCI compared to 2.3% in Group 1 (P = 0.522-NS). Mortality in patients who did not receive PPCI in Group 2 was 8% compared to 11.3% in Group 1 (P = 0.49-NS) [Figure 3].
Figure 3
The difference in mortality in both groups for primary percutaneous coronary intervention versus nonprimary percutaneous coronary intervention
The difference in mortality in both groups for primary percutaneous coronary intervention versus nonprimary percutaneous coronary interventionFemales in Group 2 have about three times higher mortality. Compared to 2010, patients treated for STEMI in the past 12 months at KACC still have same, relatively low access to PPCI due mainly to persistent pattern of late presentation and prior thrombolysis, which reflect apparent lack of direct access to hospitals with PPCI facilities.
CONCLUSION
Data from 2010 at KACC showed relatively low access to PPCI for STEMI patients primarily due to late presentation and initial thrombolysis. We believe that patient access to PPCI would have improved over the past 5 years due to improved public awareness and expanding evidenced-based health provision.
DISCUSSION
Our study showed in big difference occurred in the practice of STEMI management, in the period between 2010 and 2015, regarding the access to PPCI. In North American rural communities, long transport times create challenges in access to PCI for STEMI patients. Nevertheless, the studies showed that patient access to PCI within a 60-min prehospital standard is possible in a regionalized PCI system and should be encouraged.[1415]The ground ambulance transport for patients located over 110 km from a PCI center achieved timely access. In the province of Quebec in Canada, helicopter transfer is not available. Implementation of several evidence-based strategies helped reach that goal including multiple prehospital ECGs, rerouting patients to the closest PCI center without interhospital transfer, activation of catheterization laboratory during ambulance transport, and ED bypass at PCI centers.[1316] The regional STEMI system was designed to achieve the benchmark of a 90-min interval between STEMI diagnosis and balloon inflation; this interval allows for 60-min ambulance transport and 30 min for D2B inflation. Cheskes et al. defined FMC as the moment that paramedics arrived at the scene.[1617] Using this definition, their system achieved a (median) 70-min interval between FMC and balloon inflation, for a median travel distance of 16.1 kmand a maximum distance of 49.2 km. Other studies have used a more conservative operational definition, defining FMC as the moment that the 911 call was received.[1819] A Danish study reported that median FMC to balloon interval was 93 min in a rural region for a maximum 100 km transport distance.[19]Terkelsen et al. proposed a nomenclature of delays that would track STEMI patients from symptom onset to balloon inflation: patient delay, followed by prehospital system delay, followed by D2B delay.[4162021]Time to reperfusion therapy found in our study and others was above that recommended by national and international guidelines.[2223] In general, patients do not seek medical care until 1.5–2 h after the onset of pain. This reality has not changed significantly in the past 10 years, despite the implementation of specific public policies.[24]Previous studies have identified reasons for the increase in patient's delay time. The main component of patient delay time: the perception that the symptom is self-limiting, attributing the symptoms to other conditions, fear of disturbing others, fear that the symptoms are a false alarm, lack of knowledge of the importance of quick action and lack of awareness that one should call the EMS.[2526]Comparing the two periods, there was no change in the cardiology practice. The low access to PPCI was mainly due to late presentation, and prior thrombolysis, hospital mortality rate for patients treated with PPCI remained low during the two era, relating to lack of public awareness and health provision factors in PPCI organizations.
Limitation of the study
This study was a single-center study, and patient numbers and samples are small sized compared with international centers.
Authors: Sheldon Cheskes; Linda Turner; Ruth Foggett; Maud Huiskamp; Dean Popov; Sue Thomson; Greg Sage; Randy Watson; Richard Verbeek Journal: Prehosp Emerg Care Date: 2011-08-10 Impact factor: 3.077
Authors: James C Blankenship; Thomas D Scott; Kimberly A Skelding; Thomas A Haldis; Karen Tompkins-Weber; Marie Y Sledgen; Michael A Donegan; Jeremy W Buckley; Jennifer A Sartorius; John McB Hodgson; Peter B Berger Journal: J Am Coll Cardiol Date: 2011-01-18 Impact factor: 24.094
Authors: Marcus Eng Hock Ong; Aaron Sung Lung Wong; Chong Meng Seet; Swee Guan Teo; Beng Leong Lim; Paul Jau Lueng Ong; Shieh Mei Lai; Sea Hing Ong; Francis Chun Yue Lee; Kim Poh Chan; Venkataraman Anantharaman; Terrance Siang Jin Chua; Pin Pin Pek; Huihua Li Journal: Ann Emerg Med Date: 2012-09-27 Impact factor: 5.721
Authors: Michael C Kontos; Michael C Kurz; Charlotte S Roberts; Sarah E Joyner; Laura Kreisa; Joseph P Ornato; George W Vetrovec Journal: Am J Emerg Med Date: 2010-05-01 Impact factor: 2.469
Authors: Sanneke P M de Boer; Elizabeth H Barnes; Cynthia M Westerhout; R John Simes; Christopher B Granger; Adnan Kastrati; Petr Widimsky; Menko Jan de Boer; Felix Zijlstra; Eric Boersma Journal: Am Heart J Date: 2011-03 Impact factor: 4.749